Skip to main content
CPHI logo

CPHI · China Pharma Holdings, Inc.

$1.27 +0.07 (+5.83%)
Market Cap
$52.68M
Shares
40.52M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2020
Executive Total
Zhilin Li $241,600
Fiscal 2019
Executive Total
Zhilin Li $241,600
Fiscal 2018
Executive Total
Zhilin Li $241,600
Key facts CIK 1106644 CUSIP 16941T401